Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in a Significant China Licensing Transaction
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
📰 Thomas Paschall News
Thomas Paschall News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Thomas Paschall. Real-time updates on events, politics, business and more.